GlyEco International, Inc. (OTCMKTS:GLYE) is an industrial biotechnology company focused on the development and commercialization of enzyme‐based process solutions designed to reduce manufacturing costs and environmental impact for commodity plastics. The company leverages proprietary enzyme technologies to break down or modify polymer structures, enabling more efficient recycling and production workflows in industries that rely heavily on plastics, such as packaging, textiles and automotive components.
At the core of GlyEco’s offering are custom‐engineered enzyme systems that target key steps in the manufacture and recycling of polyethylene terephthalate (PET) and related polyesters. By integrating these biocatalysts into existing processing lines, GlyEco aims to lower energy requirements, decrease dependence on harsh chemical catalysts and generate high‐purity monomer streams suitable for reuse. This approach supports a circular economy model by enhancing the yield and quality of recycled materials while reducing greenhouse gas emissions.
Founded in the late 1990s and headquartered in Florida, GlyEco has secured a portfolio of patents covering enzymatic hydrolysis techniques and reactor designs for plastic-to-monomer conversion. The company’s pilot facilities have demonstrated scalability of its core technologies, and GlyEco continues to engage with strategic partners to advance commercial-scale deployments. While its primary market to date has been North America, the underlying enzyme platforms are adaptable to global production environments.
With a leadership team experienced in both biotechnology research and chemical manufacturing, GlyEco positions itself at the intersection of innovation and sustainability. The company’s mission is to offer cost‐competitive, green alternatives to traditional plastic processing methods, providing major polymers producers and converters with a pathway to lower costs and reduced environmental footprint.
AI Generated. May Contain Errors.
